This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
VANCOUVER, B.C., March 20, 2013 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that it will hold a conference call and webcast on Wednesday, March 27, 2013 at 1:30 pm Pacific Time (4:30 pm Eastern Time) to provide a corporate update and report year-end 2012 financial results.
Conference Call and Webcast Information
A live webcast of the call can be accessed through the Investor section of Tekmira's website at
www.tekmirapharm.com . Or, alternatively, to access the conference call, please dial 914-495-8556 or 1-866-393-1607.
An archived webcast will be available on the Tekmira website approximately two hours after the event. Alternatively, to access a replay of the conference call, please dial 404-537-3406 or 1-855-859-2056 and reference conference ID 26000337.
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Tekmira has been working in the field of nucleic acid delivery for over a decade and has broad intellectual property covering LNPs. Further information about Tekmira can be found at
www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.
Director, Investor Relations
Longview Communications Inc.